HAILEY EMERSON: Open Payments
NPI 1750019378 · ONEONTA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 12 payments from 11 companies in 2025. Trend: 2023 $34 · 2024 $426 · 2025 $298
Food & beverage: $255Education: $43
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Astellas Pharma US Inc | 1 | $32 |
| GENZYME CORPORATION | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Iovance Biotherapeutics, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| ARRAY BIOPHARMA INC | 1 | $17 |
| Eisai Inc. | 1 | $17 |
Products named: ENHERTU, Padcev, ERLEADA, SARCLISA, ULTOMIRIS, RYBREVANT, Amtagvi, KEYTRUDA.
Industry payments across NY — which companies pay providers there.
